期刊文献+

肺癌病理类型分布的研究 被引量:1

Research on distribution of pathological types in lung cancer
下载PDF
导出
摘要 目的探讨肺癌病理类型分布变化趋势,为肺癌防治工作及准确分型提供参考。方法回顾性收集2015—2019年某三甲医院经病理确诊的肺癌患者,分析肺癌病理类型的变化。结果806例肺癌患者性别以男性为主(73.2%),年龄以老年人为主(67%)。肺癌病理类型总体以腺癌为主(46.3%),其次是鳞癌(37.3%);男性以鳞癌为主(47.8%、),其次是腺癌(33.7%),女性以腺癌为主(80.6%)(P<0.01)。青年组肺癌病理类型以腺癌为主(58.5%);中年和老年组,男性以鳞癌为主(48.5%,48.7%),腺癌其次(32.7%,32.9%),女性以腺癌为主(85.2%,79.7%)(P<0.01)。结论肺癌病理类型分布受性别构成比的影响。 Objective To investigate the distribution change trend of pathological types in lung cancer,so as to provide reference for prevention and treatment as well as accurate classification of lung cancer.Methods Retrospective collection of lung cancer patients who were diagnosed pathologically in a third-class hospital from 2015 to 2019 was carried out,and the changes in pathological types of lung cancer were analyzed.Results Among 806 cases of lung cancer patients,males(73.2%)and the elderly(67%)accounted for the majority.The pathological type of lung cancer was mainly adenocarcinoma(46.3%),followed by squamous cell carcinoma(37.3%).Among male patients,squamous cell carcinoma accounted for the majority(47.8%),followed by adenocarcinoma(33.7%);among female patients,adenocarcinoma accounted for the majority(80.6%)(P<0.01).Adenocarcinoma was the main pathological type of lung cancer in young group(58.5%).In the middle-aged and elderly groups,squamous cell carcinoma was predominant in males(48.5%,48.7%),followed by adenocarcinoma was second(32.7%,32.9%),and adenocarcinoma was predominant in females(85.2%,79.7%)(P<0.01).Conclusion The pathological type distribution of lung cancer is affected by gender ratio.
作者 熊云刚 成克伦 顾延会 Xiong Yungang;Cheng Kelun;Gu Yanhui(The Guizhou Aerospace Hospital,Zunyi,Guizhou 563000;The Affiliated Hospital of Zunyi Medical University,Zunyi,Guizhou 563000)
出处 《基层医学论坛》 2022年第25期69-71,92,F0003,共5页 The Medical Forum
关键词 肺癌 病理类型 分布 临床分型 Lung cancer Pathological type Distribution Clincial classification
  • 相关文献

参考文献10

二级参考文献125

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1054
  • 2王瑾,许峰,周清华.肺癌流行病学研究进展[J].中国肺癌杂志,2005,8(5):395-400. 被引量:59
  • 3谷旭红,万会丽.110例肺癌病例分析[J].实用诊断与治疗杂志,2006,20(9):693-694. 被引量:6
  • 4邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:152
  • 5Doll R,Hill AB. Smoking and Carcinoma of the Lung; preliminary report. Br Med J,1950,2:739-748. 被引量:1
  • 6Wakelee HA, Chang ET, Gomez SL,et al. Lung cancer incidence in never smokers. J Clin Oncol,2007,25:472-478. 被引量:1
  • 7Sardari Nia P, Weyler J, Colpaert C, et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer, 2005,47 : 351-359. 被引量:1
  • 8Shriver SP, Bourdeau HA, Gubish CT, et al. Sex-specific expression of gastrin-realing peptide receptor-relationship to smoking history and risk of lung cancer. J Natl Cancer Inst,2000,92:24-33. 被引量:1
  • 9Van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, Stage Ⅰ, Ⅱ, and ⅢA. Chest,2000,117 : 374 -379. 被引量:1
  • 10Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomized, placebo-controlled, muhicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet ,2005,366 : 1527 -1537. 被引量:1

共引文献467

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部